Actinomycetes are probably the most important group of microorganisms due to their ability to produce a large number of antibiotics and other bioactive secondary metabolites [1] [2] [3] [4] [5] . In the course of screening for new biologically active compounds from marine-derived microorganisms, we found the actinomycete Saccharothrix espanaensis An 113 associated with the marine mollusk Anadara broughtoni, which produced compounds with antimicrobial activity against Gram-positive and Gram-negative bacteria, and yeast. It has been reported that actinomycetes isolated from soil or shallow sea mud are a source of the angucycline/ angucyclinone group of antibiotics which comprises more than one hundred substances [6] . These compounds are based on a tetracyclic benz [a] anthracene system with a characteristic angular array and with a high number of oxygen groups [7, 8] . In this paper we report the isolation, physico-chemical properties, biological activity and structure determination of three new derivatives of benz [a] anthracene, saccharothrixins A (6), B (7) and C (8) .
The dried EtOAc extract of culture broth was dissolved in methanol and deposited upon refrigeration. The precipitated material was crystallized twice from methanol to yield an individual compound 1 ( Figure 1 ). The obtained supernatant was chromatographed on a silica gel column with n-hexane-EtOAc (8:1, 6:1, 3:1, 1:1) and EtOAc. The active, combined n-hexane-EtOAc 8:1 and 6:1 fractions were purified by preparative TLC to give compounds 2-5 ( Figure 1 ). The active n-hexaneEtOAc 1:1 fraction was chromatographed on a silica gel column using dichloromethane and subsequently a linear dichloromethane-EtOAc gradient as mobile phase. Further purification of the dichloromethane EtOAc (3:1) fraction by reversed-phase HPLC gave components 6-8. Component 1 was obtained in a larger quantity compared with those of the remaining seven compounds. The structural elucidation of this compound, based on spectral analyses and a single crystal X-ray diffraction analysis, showed that 1 is identical to the known antibiotic X-14881 A [9] . The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated the deposition number CCDC 685854. Compounds 2-5 were isolated as minor components and identified on the basis of chemical and spectral data as the likewise known antibiotics, X-14881 E (2), X-14881 C (4), X-14881 B (5), [9, 10] and ochromycinone (3) [11] .
Compounds A (6), B (7), and C (8) were obtained as colorless prisms with a UV spectrum similar to that of 1, suggesting the same chromophore groups (248 and 280 nm). The IR spectra showed the absorption due to a hydroxy group (3540 cm -1 ) and hydrogenbonded α, β-conjugated carbonyl (1645 cm -1 ), which was further confirmed by a ketone carbonyl carbon signal at δ 202.9, 202.6 and 201.0 for 6-8, respectively, in the 13 C NMR spectrum ( Table 1 ). The highest mass peaks in the EIMS of 6-8 were observed at m/z 342. In view of the propensity of these substances to generate ion peaks by dehydration, the m/z 342 peak was interpreted as M-H 2 O and differs from that of 1 in the presence of one additional oxygen atom. The molecular formulae of 6-8 were determined as C 20 could be attributed to one carbonyl carbon, six aromatic carbons (including three methine groups, one methoxylated quaternary carbon, two quaternary carbons), four other oxygen-bearing carbon signals (including three oxygenated methine groups and one oxygenated quaternary carbon), one methyl group, three methylene groups, two methine groups and two quaternary carbons. Inspection of the 1D-and 2D-NMR data, particularly in respect to the longrange H, C-couplings, showed the compounds to have a carbon skeleton of benz[a]anthracene.
The 1 H and 13 C NMR spectra of 6-8 (Tables 1, 2 ) were similar to that of 1. In addition to the major spectral features of 1, the 1 H and 13 C NMR spectra of 6-8 exhibited the presence of one additional secondary hydroxy group in each of these compounds (δ H 4.51 -δ C 66.6; 3.88 -69.2; and 3.74 -74.9, respectively). The 1 H-NMR spectra of 6-8 showed an ABX type system of three aromatic protons at δ H 6.87, 7.1 and 7.2 ppm (H-9, H-11 and H-10). The structures of compounds 6-8, including the aromatic chromophores, were elucidated by HMBC experiments ( Table 2) .
1 H - 13 C meta couplings were observed between ortho-placed aromatic protons and their relevant carbons (H-9 to C-7a and C-11; H-10 to C-8 and C-11a and H-11 to C-7a, C-9 and C-12). A methoxy function was placed at C-8 due to a HBMC correlation between the proton signals at δ H 3.8 (H 3 -14) and C-8 (δ C 157.8), as well as NOESY correlations of these protons with H-7 and H-9. Thus, atoms C-7a, C-8, C-11a and C-12 were assigned. The HMBC spectrum of compound 6 ( Table 2) exhibited correlations of H-12 (δ H 4.63) with C-12b (δ C 131.9), C-6a (δ C 71.0) and C-7a (δ C 124.5). HMBC correlations of protons 6a-OH Table 2) , as well as correlation of H-12a (δ H 2.68) with C-12b (δ C 131.9) and C-4a (δ C 166.2) defined the structures of the C, and D-rings, and partly of rings A and B. The chemical shift values of carbon atoms C-12b (δ C 131.9) and C-4a (δ C 166.2), as well as the correlations between H 2 -2 (δ H 1.98, 2.52) and C-1 (δ C 202.9); H 3 -13 (δ H 1.04) with C-2 (δ C 45.5), C-3 (δ C 27.3) and C-4 (δ C 36.3); and H 2 -4 (δ H 2.23, 2.53) with C-4a and C-12b completed the construction of the A-ring and showed that the additional hydroxy group must occupy only either the C-5 or C-6 position. The presence of HMBC correlations between 5-OH (δ H 5.14) and C-4a (δ C 166.2), and between H-5 (δ H 4.51) and C-12b indicated the attachment of the hydroxy group at C-5 in compound 6. The orientation of this hydroxy group as 5α was defined on the basis of the 1 H-1 H coupling constants (J = 11.1, 12.3 Hz) observed for the signal of H-6α (δ H 1.24 dd), as well as the existence of a NOESY cross peak between 6а-OH and H-5. The NOESY correlations of H-11/H-12; 12-OH/H-12a; H-12a/H-7, H-6α; H-2α, β/H-13; and H-4α, β/H-13 (Table 1) established the stereochemistry of the remaining part of 6, as for 1.
Finally, the structure of 6 is either [3R-(3α, 5α, 6aβ, 7β, 12α, 12aα)]-or [3S-(3β, 5β, 6aα, 7α, 12β, 12aβ)]-3,4,5,6,6a,7,12,12a-octahydro-5,6a,7,12-tetrahydroxy-8-methoxy-3-methylbenz[a]anthracen-1(2H)-one ( Figure 1 ). In compounds 7 and 8, an additional hydroxy group is placed in ring A. This conclusion is confirmed by the existence of the distinct spin system -CH 2 -CH(CH 3 )-CH(OH)-in their 1 H-1 H COSY spectra (Figure 1) , and by the upfield chemical shifts of C-13 (δ C 16.1, 17.3) when compared with that in compound 6 (δ C 20.4). The HMBC spectra of 7 and 8 exhibited correlation of H-2 (δ H 2.33; 2.05, 2.49) with C-1 (δ C 202.6; 201.0). Therefore, an additional hydroxy group is placed at C-4 in the A-ring of both compounds 7 and 8 and they are diastereoisomers. The position of the hydroxy group at C-4 and the α-orientation of this group in 7 is confirmed by the upfield chemical shift of C-2 (δ C 39.8) in comparison with that for compound 6 (δ C 45.5, γ-effect), and by the presence of a cross-peak between 4-OH and H-2α (δ H 2.33) in the NOESY spectrum of 7. The structure and stereochemistry of the B, C and D rings in 7 are identical to those of 1 due to HMBC and NOESY correlations, as described for 6 above. On the basis of the above results the structure of 7 was determined to be either [3R-(3α, 4α, 6aβ, 7β, 12α, 12aα) ]-or [3S-(3β, 4β, 6aα, 7α, 12β, 12aβ)]-3,4,5,6,6a,7,12, 12a-octahydro-4,6a,7,12-tetrahydroxy-8-methoxy-3-methylbenz[a]anthracen-1(2H)-one ( Figure 1) . The NOESY spectrum of compound 8 (Table 1) revealed correlations between H-2α (δ H 2.05, dd, 13.3, 17.7) and H-4 (δ H 3.74), which indicated a trans-array of H-4 to H-3, and β-orientation of the 4-OH group. From the above mentioned results, the structure of 8 was determined to be either [3R- (3α, 4β, 6aβ, 7β, 12α, 12aα)]-or [3S-(3β, 4α, 6aα, 7α,  12β, 12aβ)]-3,4,5,6,6a,7,12,12a-octahydro-4 ,6a,7,12-tetrahydroxy-8-methoxy-3-methylbenz[a]anthracen-1(2H)-one (Figure 1 ).
Compounds 1-8 were assayed for antimicrobial activity at IC values of 100 μg/mL. For the first time, compound 1 was shown to exhibit moderate inhibitory activity against C. albicans and weak activity against B. subtilis and E. faecium. Compounds 2-5 possessed significant activity against C. albicans, B. subtilis, E. faecium, S. aureus and Xanthomonas sp. pv. badrii, whereas activities of compounds 6-8 against B. subtilis, E. faecium, and Xanthomonas sp. pv. badrii were only modest.
Experimental
Melting points were measured on a Leica Galen III instrument (Germany). Optical rotations were taken on a Perkin Elmer Polarimeter Model 343 (Germany). IR spectra were obtained on a Specord M-82 (Carl Zeiss, Jena) spectrometer in CHCl 3 and UV spectra were recorded on a UV spectrophotometer CECIL, CE 7250, 7000 series (England) in methanol. X-ray diffraction analysis was performed on a faceted prismatic single crystal with the dimensions 0.08 x 0.21 mm on a SMART 1000 CCD difractometer (MO-Ka-radiation, graphite monochromator) at 173(1) K.
1 H and 13 C NMR spectra were recorded on a Bruker DRX-500 spectrometer (Germany) operating at 500 and 125.6 MHz, respectively, using (CD 3 ) 2 SO as an internal standard (δ H . 2.49, δ C 39.5). HRESIMS were recorded on an ESIMS Agilent 6510 Q-TOF MS instrument (USA). EIMS were measured on an EIMS AMD 604 S instrument (Germany), 70eV. HPLC analysis was conducted with an Agilent 1100 Series instrument (USA) on a Diaspher-110-C18 column (4.0 x 250 mm, 5 μm, BioChemMack). The system was operated at a flow rate of 0.7 mL/min with solvents A:B (methanol-water, v/v, 50:50), detection by UV absorption at 226 nm. Low pressure column liquid chromatography was performed using silica gel L 100/160 (Lachema, Czech Republic). Silica gel plates, 4.5 x 6.0 cm (5-17 µm, Sorbfil, Russia) were used for thin layer chromatography in CHCl 3 -EtOH (40:1, system 1) and CHCl 3 -EtOH (20:1, system 2). Substances were visualized by spraying chromatograms with 10% ethanolic sulfuric acid followed by heating at 120°C. 
Strain isolation and cultivation:

Extraction and isolation:
The fermentation broth (3 L) was filtered and twice extracted with an equal volume of EtOAc. The combined organic layers were conc. to dryness in vacuo, resuspended in 10 mL MeOH and refrigerated. The precipitated crystals were crystallized twice from methanol to yield an individual compound 1 (70 mg). The supernatant was evaporated, the residue (700 mg) applied to a silica gel column, and eluted with n-hexane-EtOAc (8:1, 6:1, 3:1, 1:1) and EtOAc. The active eluate from the combined n-hexane-EtOAc 8:1 and 6:1 fractions was concentrated to dryness and purified by preparative TLC (system 1) yielding 2-5. The second active fraction (n-hexane-EtOAc, 1:1), containing compounds with lower R f values (system 2), was evaporated to dryness and the residue (195 mg) chromatographed on a column of silica gel, eluting first with dichloromethane and later with a linear dichloromethane-EtOAc gradient. Further purification of the dichloromethane EtOAc (3:1) fraction by reversed-phase HPLC chromatography gave components 6 (25 mg), 7 (20 mg) and 8 (20 mg).
Antimicrobial assay: The inhibitory activity against indicator bacteria and yeast was determined by an agar diffusion method. /LMG Bacteria Collection, Gent, Belgium). In the antimicrobial activity assay, an aliquot of 100 μL of compound (100 μg/100 μL, in 10% ethanol) was placed in the wells (9 mm in diameter) cut from the agar plates, which had been preliminarily inoculated with a suspension of an indicator culture (10 8 cell mL -1 ). Following incubation for 3-6 days, clear inhibition zones formed around the wells were considered indicative of antimicrobial activity.
